Metabolic profile determination of 25N-NBOMe in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry

被引:9
作者
Seo, Hyewon [1 ]
Kim, In Sook [2 ,3 ]
Kim, Young-Hoop [1 ]
Yoo, Hye Hyun [2 ,3 ]
Hong, Jin [1 ,4 ]
机构
[1] Minist Food & Drug Safety, Toxicol & Res Dept, Pharmacol Res Div, Natl Inst Food & Drug Safety Evaluat, Cheongwon Gun 28159, South Korea
[2] Hanyang Univ, Inst Pharmaceut Sci & Technol, Ansan 15588, Gyeonggi Do, South Korea
[3] Hanyang Univ, Coll Pharm, Ansan 15588, Gyeonggi Do, South Korea
[4] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea
关键词
25N-NBOMe; Human liver microsomes; Metabolism; LC-Q-TOF/MS; RAT URINE; 25I-NBOME; MS/MS; DRUG; MS;
D O I
10.1007/s00414-018-1904-7
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
2-(2,5-Dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamine (25N-NBOMe, 2C-N-NBOMe, NBOMe-2C-N) is a novel synthetic psychoactive substance of the phenethylamine chemical class. A few metabolism studies have been conducted for 25I-NBOMe, 25B-NBOMe, and 25C-NBOMe, and others, whereas 25N-NBOMe metabolism has not been researched. In this study, the in vitro metabolism of 25N-NBOMe was investigated with human liver microsomes, and the reaction mixture was analyzed using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-Q-TOF/MS). Formation of 14 metabolites (M1-M14) was yielded with incubation of 25N-NBOMe in human liver microsomes in the presence of NADPH. The metabolites were structurally characterized on the basis of accurate mass analysis and MS/MS fragmentation patterns. The biotransformations included hydroxylation, O-demethylation, N-dealkylation, nitro reduction, dehydrogenation, carbonylation, and combinations thereof. Hydroxyl metabolite was the most abundant compound after the phase I process. These results provide helpful information establishing biomarkers in case of 25N-NBOMe ingestion.
引用
收藏
页码:833 / 841
页数:9
相关论文
共 15 条
  • [1] [Anonymous], 2014, EMCDDA EUR JOINT REP
  • [2] Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MSE accurate-mass spectra
    Bijlsma, Lubertus
    Sancho, Juan V.
    Hernandez, Felix
    Niessen, Wilfried M. A.
    [J]. JOURNAL OF MASS SPECTROMETRY, 2011, 46 (09): : 865 - 875
  • [3] In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS
    Boumrah, Yacine
    Humbert, Luc
    Phanithavong, Melodie
    Khimeche, Kamel
    Dahmani, Abdallah
    Allorge, Delphine
    [J]. DRUG TESTING AND ANALYSIS, 2016, 8 (02) : 248 - 256
  • [4] LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques
    Caspar, Achim T.
    Westphal, Folker
    Meyer, Markus R.
    Maurer, Hans H.
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2018, 410 (03) : 897 - 912
  • [5] Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MSn, and LC-HR-MS/MS
    Caspar, Achim T.
    Helfer, Andreas G.
    Michely, Julian A.
    Auwaerter, Volker
    Brandt, Simon D.
    Meyer, Markus R.
    Maurer, Hans H.
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2015, 407 (22) : 6697 - 6719
  • [6] Comparative metabolism study of β-lapachone in mouse, rat, dog, monkey, and human liver microsomes using liquid chromatography-tandem mass spectrometry
    Lee, Sangkyu
    Kim, In Sook
    Kwak, Tae Hwan
    Yoo, Hye Hyun
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 83 : 286 - 292
  • [7] Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH
    Nielsen, Line Marie
    Holm, Niels Bjerre
    Leth-Petersen, Sebastian
    Kristensen, Jesper Langgaard
    Olsen, Lars
    Linnet, Kristian
    [J]. DRUG TESTING AND ANALYSIS, 2017, 9 (05) : 671 - 679
  • [8] Suzuki J, 2015, PSYCHOSOMATICS, V56, P129, DOI 10.1016/j.psym.2014.11.002
  • [9] Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine
    Temporal, Keith-Dane H.
    Scott, Karen S.
    Mohr, Amanda L. A.
    Logan, Barry K.
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2017, 41 (07) : 646 - 657
  • [10] New Psychoactive Substances: Chemistry, Pharmacology, Metabolism, and Detectability of Amphetamine Derivatives With Modified Ring Systems
    Welter-Luedeke, Jessica
    Maurer, Hans H.
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (01) : 4 - 11